Bustamante et al. (2017) explored a 21-biomarker panel for stroke differentiation, finding that NT-proBNP and endostatin, combined with clinical variables, could help differentiate between ischemic and hemorrhagic stroke [18]. This evidence concerns the gene NPPB and stroke disorder.